Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/vaccines10070992 http://scihub22266oqcxt.onion/10.3390/vaccines10070992 35891156!9325163!35891156     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Vaccines+(Basel) 2022 ; 10 (7): ä Nephropedia Template TP {{tp|p=35891156|t=2022. Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants |pdf=|usr=}}{{35891156}} gab.com Text Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants JO: Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=35891156 #FOAvip The reactivation of latent viruses during SARS-CoV-2 infection is well recognized, and coinfection with Epstein-Barr virus (EBV) has been associated with severe clinical cases of COVID-19 infection. In transplant patients, EBV infection presents a significant challenge. Assessing the potential impact of SARS-CoV-2 vaccinations on EBV infections in stable kidney and liver transplant recipients was the objective of our study. Ten solid-organ-transplant (SOT) patients (eight kidney and two liver) vaccinated with standard doses of mRNA COVID-19 vaccines were included. EBV DNA viral load measurements were conducted prior to the vaccination and during a follow-up period (at the first month and after six months) after the second vaccine dose. After the second dose, a significant increase in median viremia was observed (p < 0.01) in 9 patients, and in one patient, the reactivation of EBV infection was found. Six months later, the median viremia decreased significantly (p < 0.05). The EBV viral load should be closely monitored as it could lead to the earlier diagnosis and treatment of EBV-related complications. Despite experiencing a decrease in the viral load six months post-vaccination, some patients still had a viral load over the baseline, which increased the risk of potential complications. Twit Text FOAVip Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants ????Vaccines (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=35891156 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=35891156 #FOAvip English Wikipedia <ref>{{Cite pmid|35891156}}</ref> Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants #MMPMID35891156 Musialik J; Kolonko A; Wiecek A Vaccines (Basel) 2022[Jun]; 10 (7): ä PMID35891156show ga The reactivation of latent viruses during SARS-CoV-2 infection is well recognized, and coinfection with Epstein-Barr virus (EBV) has been associated with severe clinical cases of COVID-19 infection. In transplant patients, EBV infection presents a significant challenge. Assessing the potential impact of SARS-CoV-2 vaccinations on EBV infections in stable kidney and liver transplant recipients was the objective of our study. Ten solid-organ-transplant (SOT) patients (eight kidney and two liver) vaccinated with standard doses of mRNA COVID-19 vaccines were included. EBV DNA viral load measurements were conducted prior to the vaccination and during a follow-up period (at the first month and after six months) after the second vaccine dose. After the second dose, a significant increase in median viremia was observed (p < 0.01) in 9 patients, and in one patient, the reactivation of EBV infection was found. Six months later, the median viremia decreased significantly (p < 0.05). The EBV viral load should be closely monitored as it could lead to the earlier diagnosis and treatment of EBV-related complications. Despite experiencing a decrease in the viral load six months post-vaccination, some patients still had a viral load over the baseline, which increased the risk of potential complications. äIncreased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ(epmc).pdf DeepDyve Pubget Overpricing